Planet Briefing

First published · Last updated

Safety and Effectiveness of Caplacizumab in Pediatric Patients With iTTP: Real-World Experience

A peer-reviewed journal article published 2026-09-01 reports real-world clinical experience with caplacizumab in children with immune TTP. The supplied excerpt included only publisher and content type and provided no study details or results.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
6/10
Geographic reach
1/10
Global importance
2/10
Impact magnitude
2/10
Positivity
5/10
Urgency
2/10

Why it matters

The article addresses safety and effectiveness of a therapy in a pediatric rare-disease population, which is relevant to clinicians and researchers.

Sources

Report an issue